Correlation of high PRDX4 expression with poor prognosis in patients with ESCA: Bioinformatics and in vitro validation
Molecular and Clinical Oncology · 17.09.2026 · 25 (5) · 1-12
DOI: 10.3892/mco.2026.2976 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular and Clinical Oncology, online erschienen am 17.09.2026. Verfasst von Xing Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency, The Second People's Hospital of Futian District Shenzhen, Shenzhen, Guangdong 518049, P.R. China. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Emergency, The Second People's Hospital of Futian District Shenzhen, Shenzhen, Guangdong 518049, P.R. China.
- Neurology Department, Helan People's Hospital, Yinchuan, Ningxia Hui Autonomous Region 750200, P.R. China.
- Department of Radiotherapy, General Hospital of Ningxia Medical University, Yinchuan, Ningxia Hui Autonomous Region 750003, P.R. China.
Zitieren
APA
Liu, X., Pan, L., Song, H., & Pan, W. (2026). Correlation of high PRDX4 expression with poor prognosis in patients with ESCA: Bioinformatics and in vitro validation. Molecular and Clinical Oncology, 25(5), 1-12. https://doi.org/10.3892/mco.2026.2976
Vancouver
Liu X, Pan L, Song H, Pan W. Correlation of high PRDX4 expression with poor prognosis in patients with ESCA: Bioinformatics and in vitro validation. Molecular and Clinical Oncology. 2026;25(5):1-12. doi:10.3892/mco.2026.2976
BibTeX
@article{Liu2026,
author = {Liu, Xing and Pan, Lanlan and Song, Huichao and Pan, Wenyan},
title = {Correlation of high PRDX4 expression with poor prognosis in patients with ESCA: Bioinformatics and in vitro validation},
journal = {Molecular and Clinical Oncology},
year = {2026},
volume = {25},
number = {5},
pages = {1--12},
doi = {10.3892/mco.2026.2976}
}
EUVIMED